Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-14 | Elizabeth McKee Anderson joined our Board in July 2019. Ms. Anderson held various senior leadership positions at Johnson & Johnson between 2003 and her retirement in 2014. She most recently served as Worldwide Vice President, Infectious Disease and Vaccines for Janssen Pharmaceuticals, a Johnson & Johnson company. |
| 2021-04-13 | Elizabeth McKee Anderson joined our Board in July 2019. Ms. Anderson held various senior leadership positions at Johnson & Johnson between 2003 and her retirement in 2014. She most recently served as Worldwide Vice President, Infectious Disease and Vaccines for Janssen Pharmaceuticals, a Johnson & Johnson company, where she directed the commercial development of an extensive portfolio of antivirals and vaccines with responsibility for global strategic marketing, market access, and global analytics for that division. Ms. Anderson currently serves on the boards of Bavarian Nordic A/S, Insmed, Inc. and Revolution Medicines, Inc., public biopharmaceutical companies. The Audit Committee is currently composed of four directors: Mr. Hombach (Chair), Dr. Heron, Dr. Ho and Dr. Lawlis. The Board has determined that all members of our Audit Committee are independent. Ms. Anderson was a member of the Audit Committee when the Audit Committee submitted this report. Subsequently, Ms. Anderson joined the Compensation Committee and was replaced on the Audit Committee by Dr. Ho. 2020 INDEPENDENT DIRECTOR COMPENSATION: Elizabeth McKee Anderson Fees Earned ($) 87,250 Stock Awards ($) 458,810 Total ($) 546,060. |
| 2022-04-12 | Elizabeth McKee Anderson, 64, Director Since July 2019, Former Worldwide Vice President, Infectious Diseases and Vaccines, Janssen Pharmaceuticals, Inc.; Director, Bavarian Nordic A/S; Director, Insmed, Inc.; Director, Revolution Medicines, Inc. Chair of the Compensation Committee. 2021 INDEPENDENT DIRECTOR COMPENSATION: Fees Earned or Paid in Cash $94,625, Stock Awards $397,312, Total $491,937. |
| 2023-04-11 | Elizabeth McKee Anderson joined our Board in July 2019 and serves as Chair of the Compensation Committee. Ms. Anderson held various senior leadership positions at Johnson & Johnson between 2003 and her retirement in 2014. Ms. Anderson most recently served as Worldwide Vice President, Infectious Disease and Vaccines for Janssen Pharmaceuticals, a Johnson & Johnson company, where she directed the commercial development of an extensive portfolio of antivirals and vaccines with responsibility for global strategic marketing, market access, and global analytics for that division. Prior to Johnson & Johnson, Ms. Anderson served as the Vice President and General Manager of Wyeth Lederle Vaccines from 1997 to 2002. Ms. Anderson also previously worked at Rhône-Poulenc Rorer and the American Red Cross. Ms. Anderson currently serves on the boards of GSK PLC, Insmed, Inc. and Revolution Medicines, Inc., all public biopharmaceutical companies, and she formerly served on the boards of Bavarian Nordic A/S, a public vaccines and biopharmaceuticals company, through August, 2022 and Huntsworth PLC, a public healthcare and communications company, through December 31, 2019. Ms. Anderson also serves on the board of Aro Biotherapeutics Company, a private biopharmaceutical company, is an advisory board member of Naxion Inc., a private research and consulting company, is a member of the Board of Trustees of the Wistar Institute, a non-profit biomedical research organization and is the Principal of PureSight Advisory, LLC. Ms. Anderson holds a B.S. in Engineering from Rutgers University and an M.B.A. from Loyola University Maryland. |
| 2024-04-09 | Elizabeth McKee Anderson joined our Board in July 2019 and serves as Chair of the Compensation Committee. Ms. Anderson held various senior leadership positions at Johnson & Johnson from 2003 until her retirement in 2014. Ms. Anderson currently serves on the boards of GSK plc, Insmed Inc., and Revolution Medicines, Inc. ... 2023 Independent Director Compensation ... Elizabeth McKee Anderson 95,000 Fees Earned or Paid in Cash, 385,438 Stock Awards, 480,438 Total. |
| 2025-04-08 | Elizabeth McKee Anderson joined our Board in July 2019 and serves as Chair of the Compensation Committee. Ms. Anderson held various senior leadership positions at Johnson & Johnson from 2003 until her retirement in 2014. Ms. Anderson currently serves on the boards of GSK plc, Insmed, Inc., and Revolution Medicines, Inc. Ms. Anderson holds a B.S. in Engineering from Rutgers University and an M.B.A. from Loyola University Maryland. 2024 Non-Employee Director Compensation: Elizabeth McKee Anderson received total compensation of $463,545. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-04 | Education: Loyola University Maryland - M.B.A., finance; Rutgers University - B.S., engineering |
| 2020-03-31 | Education: Loyola University Maryland - M.B.A., finance; Rutgers University - B.S., engineering |
| 2021-04-01 | Education: Loyola University Maryland - M.B.A., finance; Rutgers University - B.S., engineering |
| 2022-04-01 | Education: Loyola University Maryland - M.B.A., finance; Rutgers University - B.S., engineering |
| 2023-03-31 | Education: Loyola University Maryland - M.B.A., finance; Rutgers University - B.S., engineering |
| 2024-04-01 | Education: Rutgers University - B.S., engineering. Loyola University Maryland - M.B.A., finance. Ms. Anderson has more than 30 years of leadership in biotechnology, pharmaceuticals, and vaccines. |
| 2025-04-04 | Education: Rutgers University - B.S., engineering; Loyola University Maryland - M.B.A., finance |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22